Insights into fucose metabolism: SLC35C1-independent fucosylation discriminates against mannose-derived GDP-fucose
Edyta Skurska, Bożena Szulc, Dorota Maszczak-Seneczko
Nov 23, 2021
Citations
0
Citations
Journal
Journal name not available for this finding
Full text
Semantic Scholar
Key Takeaway Key Takeaway: SLC35C1-independent fucosylation in cells can be reversed by fucose treatment, suggesting a functional connection between nucleotide sugar transporters and nucleotide sugar synthetases.
Abstract
Mutations in the SLC35C1 gene, encoding the Golgi GDP-fucose transporter, cause leukocyte adhesion deficiency II (LADII). Fucosylation improvement in LADII patients treated with fucose suggests the existence of an SLC35C1-independent route of GDP-fucose transport, which still remains a mystery. Here, we developed and characterized a human cell-based model deficient in the SLC35C1 activity. The knockout cells displayed low but detectable levels of fucosylation. Strikingly, the fucosylation defect was almost completely reversed upon treatment with millimolar concentrations of fucose. Even if fucose was supplemented at nanomolar concentrations, it was still incorporated into glycans by the knockout cells. We also found that the SLC35C1-independent transport preferred the salvage pathway over the de novo pathway as a source of GDP-fucose. Our results imply that the Golgi systems of GDP-fucose transport discriminate between the substrate pools obtained from different metabolic pathways, which suggests a functional connection between nucleotide sugar transporters and nucleotide sugar synthetases.